Previous Article | Next Article 
J Virol, April 1998, p. 2671-2676, Vol. 72, No. 4
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Packaging of Endogenous Retroviral Sequences in Retroviral
Vectors Produced by Murine and Human Packaging Cells
Clive
Patience,1,*
Yasuhiro
Takeuchi,1
Francois-Loic
Cosset,2 and
Robin A.
Weiss1
Chester Beatty Laboratories, Institute of
Cancer Research, London SW3 6JB, United
Kingdom,1 and
Centre de
Génétique Moléculaire et Cellulaire, CNRS UMR5534,
Universite Claude-Bernard Lyon-1, Villeurbanne,
France2
Received 30 July 1997/Accepted 9 December 1997
Interaction of retrovirus vectors and endogenous retroviruses
present in packaging cell lines and target cells may result in unwanted
events, such as the formation of recombinant viruses and the
mobilization of therapeutic vectors. Using sensitive reverse transcriptase PCR assays, we investigated human and murine gene therapy
packaging cell lines for incorporation of endogenous retrovirus transcripts into murine leukemia virus (MLV) vector particles and,
conversely, whether vector genomes are incorporated into human
endogenous retrovirus (HERV) particles. VL30 endogenous retrovirus
sequences were efficiently packaged in particles produced by the murine
AM12 packaging system. For every seven MLV-derived
-galactosidase
(
-Gal) vector genomes present in the particles, one copy of VL30 was
also packaged. Although human FLY packaging cells expressed several
classes of HERV transcripts (HERV-K, HuRT, type C, and RTVL-H), none
was detectable in the MLV vector particles released from the cells.
Nonspecific packaging of the MLV Gag-Pol expression vector transcripts
was detected in the FLY virions at a low level (1 in 17,000 sequences).
These findings indicate that human packaging cells produce retrovirus
particles far less contaminated by endogenous viral sequences than
murine packaging cells. Human teratocarcinoma cells (GH cells), which
produce HERV-K particles, were transduced with an MLV-derived
-Gal
vector. Although both HERV-K and RTVL-H sequences were found in
association with the particles,
-Gal transcripts were not detected,
indicating that HERV Gag proteins do not efficiently package MLV-based
vectors.
*
Corresponding author. Mailing address: Chester Beatty
Laboratories, Institute of Cancer Research, 237 Fulham Rd., London SW3 6JB, United Kingdom. Phone: 44-171-352-8133. Fax: 44-171-352-3299. E-mail: clive{at}icr.ac.uk.
This article has been cited by other articles:
-
Takeuchi, Y., McClure, M. O., Pizzato, M.
(2008). Identification of Gammaretroviruses Constitutively Released from Cell Lines Used for Human Immunodeficiency Virus Research. J. Virol.
82: 12585-12588
[Abstract]
[Full Text]
-
Baum, C., Dullmann, J., Li, Z., Fehse, B., Meyer, J., Williams, D. A., von Kalle, C.
(2003). Side effects of retroviral gene transfer into hematopoietic stem cells. Blood
101: 2099-2113
[Abstract]
[Full Text]
-
Patience, C., Switzer, W. M., Takeuchi, Y., Griffiths, D. J., Goward, M. E., Heneine, W., Stoye, J. P., Weiss, R. A.
(2001). Multiple Groups of Novel Retroviral Genomes in Pigs and Related Species. J. Virol.
75: 2771-2775
[Abstract]
[Full Text]
-
Fishman, J. A
(2000). Infection in xenotransplantation. BMJ
321: 717-718
[Full Text]
-
Palmarini, M., Hallwirth, C., York, D., Murgia, C., de Oliveira, T., Spencer, T., Fan, H.
(2000). Molecular Cloning and Functional Analysis of Three Type D Endogenous Retroviruses of Sheep Reveal a Different Cell Tropism from That of the Highly Related Exogenous Jaagsiekte Sheep Retrovirus. J. Virol.
74: 8065-8076
[Abstract]
[Full Text]
-
Buchschacher, G. L. Jr, Wong-Staal, F.
(2000). Development of lentiviral vectors for gene therapy for human diseases. Blood
95: 2499-2504
[Abstract]
[Full Text]
-
Blond, J.-L., Lavillette, D., Cheynet, V., Bouton, O., Oriol, G., Chapel-Fernandes, S., Mandrand, B., Mallet, F., Cosset, F.-L.
(2000). An Envelope Glycoprotein of the Human Endogenous Retrovirus HERV-W Is Expressed in the Human Placenta and Fuses Cells Expressing the Type D Mammalian Retrovirus Receptor. J. Virol.
74: 3321-3329
[Abstract]
[Full Text]
-
Sena-Esteves, M., Saeki, Y., Camp, S. M., Chiocca, E. A., Breakefield, X. O.
(1999). Single-Step Conversion of Cells to Retrovirus Vector Producers with Herpes Simplex Virus-Epstein-Barr Virus Hybrid Amplicons. J. Virol.
73: 10426-10439
[Abstract]
[Full Text]
-
Mikkelsen, J. G., Lund, A. H., Duch, M., Pedersen, F. S.
(1999). Forced recombination of {Psi}-modified murine leukaemia virus-based vectors with murine leukaemia-like and VL30 murine endogenous retroviruses. J. Gen. Virol.
80: 2957-2967
[Abstract]
[Full Text]
-
Lopez-Lastra, M., Ulrici, S., Gabus, C., Darlix, J.-L.
(1999). Identification of an Internal Ribosome Entry Segment in the 5' Region of the Mouse VL30 Retrotransposon and Its Use in the Development of Retroviral Vectors. J. Virol.
73: 8393-8402
[Abstract]
[Full Text]
-
Tailor, C. S., Nouri, A., Zhao, Y., Takeuchi, Y., Kabat, D.
(1999). A Sodium-Dependent Neutral-Amino-Acid Transporter Mediates Infections of Feline and Baboon Endogenous Retroviruses and Simian Type D Retroviruses. J. Virol.
73: 4470-4474
[Abstract]
[Full Text]
-
Van Den Broeke, A., Bagnis, C., Ciesiolka, M., Cleuter, Y., Gelderblom, H., Kerkhofs, P., Griebel, P., Mannoni, P., Burny, A.
(1999). In Vivo Rescue of a Silent tax-Deficient Bovine Leukemia Virus from a Tumor-Derived Ovine B-Cell Line by Recombination with a Retrovirally Transduced Wild-Type tax Gene. J. Virol.
73: 1054-1065
[Abstract]
[Full Text]